Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,037,425
+$26,500,425 QoQ
Shares Held
4,827,792
+46.3% QoQ
Ownership
5.60%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#5
of 188 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. EYPT ranks #15 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,037,425 | 4,827,792 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $42,537,000 | 3,300,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,869,000 | 4,700,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $79,171,295 | 5,559,782 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $63,988,000 | 6,800,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,604,000 | 6,200,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $42,837,500 | 5,750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,293,445 | 3,791,420 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,245,354 | 3,591,420 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $98,312,700 | 4,756,299 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $103,218,966 | 4,466,420 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,874,658 | 1,736,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,505,592 | 1,782,252 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,733,000 | 1,950,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,825,000 | 1,950,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,424,500 | 1,950,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,346,500 | 1,950,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,692,500 | 1,950,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,868,000 | 1,950,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,370,783 | 1,763,031 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,384,000 | 1,600,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,425,023 | 1,518,211 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||